EIKN

NASDAQ Healthcare

Eikon Therapeutics, Inc. - Common Stock

Biotechnology

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

�� 市场数据
价格$9.60
成交量219,608
市值519.73M
RSI（14日）38.6
50日均线$10.45
52周最高$17.40
52周最低$7.90
Forward P/E-1.64
Price / Book0.94
在Yahoo Finance查看 →
🎯 投资策略评分

EIKN 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 31/100
高股息率 + 低波动性
🚀 Moon Shot 15/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 72/100
逆向投资（超卖 + 低于移动均线）
🎈 Over-Hyped 19/100
超买股票（潜在做空标的）
🐋 Institutional Whale 14/100
大盘、机构级别股票
🔍 策略解读

最佳匹配： 🔪 Falling Knife (72/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🐋 Institutional Whale (14/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 EIKN in your text

粘贴任何文章、记录或帖子 — 工具将提取 EIKN 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-06-02.